Independent Director for Pharmaceutical Investment Oversight
Greece·Public-Interest & Regulated Services·Public-interest investment· Athens·Posted 27 July 2026
Applications close 22 November 2026
Public-interest investment organisation in Greece
The problem this seat exists to solve
The director will contribute to a pharmaceutical enterprise's board with emphasis on investment discipline, governance and the financial consequences of development choices. The role requires understanding how scientific evidence, operational capability and commercial assumptions interact. It does not confer responsibility for clinical decisions, product authorisation or specialist technical assurance.
What to challenge
Examine the rationale for material development, manufacturing or commercial investments. Ask whether the decision package makes uncertainty, dependencies and alternative uses of capital clear. Review the evidence behind timing assumptions and the resources required after the initial commitment.
Consider the relationship between investment plans and the enterprise's ability to maintain quality, supply and financial resilience. A project with strategic promise may still require sequencing or partnership to fit available capability. The director should support informed choices without allowing general enthusiasm for innovation to substitute for a defensible case.
Work with expertise responsibly
Seek clear explanations from scientific, quality, finance and commercial leaders. Recognise where independent specialist review is necessary and ensure that material reservations reach the board. The director should be able to distinguish an unresolved scientific question from a preventable governance or execution weakness.
**Qualified candidates** will have senior investment, finance or governance experience involving technically complex businesses. Pharmaceutical or adjacent life-science exposure is valuable where it provides an understanding of development and quality constraints. Candidates must explain a decision in which specialist evidence materially changed their initial investment view.
Collective board responsibilities
Contribute to strategy, risk, succession and reserved capital decisions, with committee duties agreed according to the actual entity's needs. Management retains responsibility for project execution and qualified professionals retain their technical duties. Appointment eligibility, independence and relevant conflicts must be assessed before assuming office.
Evidence of effective stewardship
The board should understand what it is funding, what progress must be demonstrated and when the case should be revisited. Success means capital decisions that acknowledge scientific uncertainty while maintaining clear accountability. The appointment should strengthen the quality of challenge and the transparency of trade-offs, helping the enterprise pursue worthwhile development without obscuring its financial or operating limits.
Terms
- Where the board sits
- Athens, Greece
- Applications close
- 22 November 2026
- Appointment
- Board appointment
- Compensation
- EUR 35,000–65,000 per year (indicative annual board fee)
- Time commitment in this market
- A regular board cycle through the year plus committees; the statute requires at least two independent directors to attend meetings that approve the financial statements.
Before you apply — Greece
No nationality or residency test applies to a director of a Greek société anonyme. The constraint is the statutory independence test, which disqualifies some candidates who would be independent elsewhere.
- Residency test
- None.
- Nationality test
- None.
- Work authorisation
- A non-executive director attending board meetings does not need Greek work authorisation. Executive roles for non-EU nationals require a residence permit for work.
- Tenure limit once appointed
- Nine financial years' cumulative service on the board of the company or its related companies — a statutory limit under Law 4706/2020 art. 9, not a code recommendation.
Also open in Greece
All seats in this market →Independent Director for Investment Concentration and Liquidity
Greece·Public-Interest & Regulated Services
Public-interest investment organisation in Greece
The director will strengthen board oversight of concentration, liquidity and future funding commitments in an investment-oriented enterprise. The role requires looking beyond individual opportunity quality to the consequences of holding the portfolio as a whole. It is a director office, not an external asset-allocation advisory engagement.
Independent Bank Director — Growth, Governance and Executive Challenge
Greece·Banking & Financial Services
Banking organisation in Greece
The director will contribute independent banking judgement to a board considering growth, organisational change and competing investment priorities. The role requires a broad view of the institution, linking commercial plans with capital, people, controls, customer outcomes and the capacity of management to execute.
Nonexecutive Director for Utility Capital Investment Oversight
Greece·Energy & Utilities
Municipal and regional infrastructure
A utility is accelerating network and treatment infrastructure spending after years of deferred renewal. The director will help the board assess project prioritisation, procurement discipline and delivery readiness so scarce capital addresses the most material service and asset risks. You will challenge the evidence used to prioritise renewal projects, including asset condition, service impact and affordability.
Global ID Exchange
One account. Every market your record travels to.
Registering is free and you can apply straight away — one application a fortnight. Pass the free assessment and you are certified for a year, with one application a week. Foresight Infinity (US$250 a month) raises that to one application a day and carries your applications ahead of free members; Foresight Infinity Plus (US$500 a month) carries them first, the moment they arrive.